======= C18orf8 ======= == Gene Information == * **Official Symbol**: RMC1 * **Official Name**: regulator of MON1-CCZ1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29919|29919]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96DM3|Q96DM3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=C18orf8&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C18orf8|Open PubMed]] * **OMIM**: [[https://omim.org/entry/620267|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a colon cancer associated protein. [provided by RefSeq, Jan 2013]. * **UniProt Summary**: Componement of the CCZ1-MON1 RAB7A guanine exchange factor (GEF). Acts as a positive regulator of CCZ1-MON1A/B function necessary for endosomal/autophagic flux and efficient RAB7A localization (PubMed:29038162). {ECO:0000269|PubMed:29038162}. |Mic1| |Mon1-Ccz1 complex| |late endosome membrane| |autophagy| |process utilizing autophagic mechanism| |lysosomal membrane| |regulation of autophagy| |regulation of cellular catabolic process| |regulation of catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-2.91| |[[:results:exp169|BH1 1μM R04 exp169]]|-2.36| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|-2.24| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-2.21| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.06| |[[:results:exp73|LJH685 5μM R02 exp73]]|-1.87| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.77| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.76| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-1.73| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|1.71| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|1.74| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|1.77| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|1.88| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|2.09| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|2.09| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|2.15| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|2.65| ^Gene^Correlation^ |[[:human genes:c:ccz1|CCZ1]]|0.431| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14707 * **Expression level (log2 read counts)**: 4.9 {{:chemogenomics:nalm6 dist.png?nolink |}}